Recent Study Suggests Model to Address Research Gaps and Unmet Needs in Oral Adherence for Lymphoma
Several oral agents have been proven active in the treatment of certain subtypes of non-Hodgkin…
Several oral agents have been proven active in the treatment of certain subtypes of non-Hodgkin…
In a study funded in part by the Lymphoma Research Foundation, researchers find the loss…
Rituximab (Rituxan) has long been the standard of care for many lymphoma patients with relapsed…
At the 2018 ASH Annual Meeting, Catherine Diefenbach, MD (New York University) – a past…
As novel treatments have increased survival rates and changed treatment paradigms for lymphoma, the need…
In conjunction with the Mantle Cell Lymphoma Scientific Workshop, the Lymphoma Research Foundation announced…
The Lymphoma Research Foundation (LRF) is pleased to announce that scientific proceedings and priorities from…
Lymphoma Research Foundation Publishes White Paper to Outline Key Issues Discussed During Second Oral Therapies…
Oral medications are being increasingly used to treat patients with lymphoma and chronic lymphocytic leukemia…